Results 161 to 170 of about 51,650 (294)

Phase 1 Study Evaluating the Pharmacokinetics, Dose Proportionality, Bioavailability, and Tolerability of Subcutaneous Levothyroxine Sodium (XP‐8121)

open access: yesClinical and Translational Science
Levothyroxine sodium has been the cornerstone of hypothyroidism management worldwide, with daily oral administration (PO) recognized as standard of care.
Richard Fitch   +4 more
doaj   +1 more source

Comparing Blood Pressure in Pregnant Women with Subclinical Hypothyroidism Using Levothyroxine to those with Euthyroid Status

open access: yesAdvanced Biomedical Research
Background: Subclinical hypothyroidism (SCH) is a common condition during pregnancy that can be treated with levothyroxine at a dosage of 0.5–1 mcg/kg/day. If left untreated, the risk of hypertensive disorders of pregnancy increases.
Afsaneh Halili   +5 more
doaj   +1 more source

People on Drugs: Credibility of User Statements in Health Communities

open access: yes, 2017
Online health communities are a valuable source of information for patients and physicians. However, such user-generated resources are often plagued by inaccuracies and misinformation.
Danescu-Niculescu-Mizil, Cristian   +2 more
core  

Concluding Remarks [PDF]

open access: yes, 1985
Beysel, D.   +3 more
core   +1 more source

Chromosome Translocation Frequency after Radioiodine Thyroid Remnant Ablation: A Comparison between Recombinant Human Thyrotropin Stimulation and Prolonged Levothyroxine Withdrawal [PDF]

open access: bronze, 2009
Anna Chiara Frigo   +10 more
openalex   +1 more source

An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks’ gestation: results of the TIPIT trial [PDF]

open access: gold, 2013
Sze May Ng   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy